Search | Net Pals

Subhayan2 added blog Other
2026-06-17 10:56:24 - Translate -

Global Epidural and Spinal Anesthesia Drugs Market Growing at 5.1% CAGR
According to a new report from Intel Market Research, the global epidural and spinal anesthesia drug market was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.31 billion in 2026 to USD 1.76 billion by 2034, exhibiting a steady CAGR of 5.1% during the forecast period (2026–2034). This growth is driven by increasing surgical volumes, rising preference for minimally...

0 Comments 0 Shares 63 Views 0 Reviews

Please log in to like, share and comment!
Subhayan2 added blog Other
2026-06-17 10:56:28 - Translate -

Global Epidural and Spinal Anesthesia Drugs Market Growing at 5.1% CAGR
According to a new report from Intel Market Research, the global epidural and spinal anesthesia drug market was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.31 billion in 2026 to USD 1.76 billion by 2034, exhibiting a steady CAGR of 5.1% during the forecast period (2026–2034). This growth is driven by increasing surgical volumes, rising preference for minimally...

0 Comments 0 Shares 63 Views 0 Reviews

Please log in to like, share and comment!
Subhayan2 added blog Other
2026-06-17 10:57:05 - Translate -

Global Epidural and Spinal Anesthesia Drugs Market Growing at 5.1% CAGR
According to a new report from Intel Market Research, the global epidural and spinal anesthesia drug market was valued at USD 1.25 billion in 2025 and is projected to grow from USD 1.31 billion in 2026 to USD 1.76 billion by 2034, exhibiting a steady CAGR of 5.1% during the forecast period (2026–2034). This growth is driven by increasing surgical volumes, rising preference for minimally...

0 Comments 0 Shares 64 Views 0 Reviews

Please log in to like, share and comment!
Subhayan2 added blog Other
2026-06-18 09:59:30 - Translate -

Global Ibuprofen Market Growing at 2.9% CAGR Through 2032
According to a new report from Intel Market Research, the global ibuprofen market was valued at USD 87.4 million in 2024 and is projected to grow from USD 89.9 million in 2025 to USD 106 million by 2032, exhibiting a steady CAGR of 2.9% during the forecast period (2025–2032). This growth is driven by the increasing global burden of chronic pain conditions and inflammatory diseases, rapid...

0 Comments 0 Shares 22 Views 0 Reviews

Please log in to like, share and comment!